Cacco, Inc. (4166) AI Stock Analysis

• Market Cap: ¥1.92B
• Dividend Yield: N/A
• Average Volume (3M): 40.02K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.38
• Revenue Growth: 12.27%
• EPS Growth: 73.45%
• Country: JP
• Employees: 35
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): N/A
• Shares Outstanding: 2,732,655
• 10 Day Avg. Volume: 11,830
• 30 Day Avg. Volume: 40,016
• PEG Ratio: 0.34
• Price to Book (P/B): 3.13
• Price to Sales (P/S): 2.68
• P/FCF Ratio: -28.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: ¥706.00 ▼(-20.50% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held back mainly by weak financial performance—ongoing losses and negative cash flow despite some improvement in 2025—and bearish technicals with the price below key moving averages and negative MACD. Valuation offers limited support due to negative earnings and no dividend yield.

Positive Factors

Manageable leverage

The balance sheet shows relatively low leverage and only moderate debt in 2025, which reduces near-term refinancing risk. This financial flexibility gives management time to execute operational fixes, fund strategic initiatives, and absorb losses without immediate solvency pressure.

Return to revenue growth in 2025

A modest top-line recovery in 2025 indicates stabilization of demand or improved sales execution. Sustained revenue growth is a durable input for restoring unit economics, supporting margin recovery, and reducing reliance on external financing over a multi-quarter horizon if maintained.

Margin recovery and narrower losses in 2025

Improving gross margins and materially narrower operating losses suggest cost controls or better pricing dynamics. Continued margin improvement would make cash burn more predictable, accelerate the path to break-even, and strengthen long-term viability even before sustained profitability is achieved.

Negative Factors

Multi-year losses and negative cash flow

Persistent operating and net losses with negative operating and free cash flow across multiple years represent a structural weakness. Continued losses erode equity, increase financing needs, and elevate execution risk if revenue and margin improvements do not become sustained.

Deteriorated cash generation since 2023

The shift from positive to persistent negative cash generation removes an internal funding source, forcing reliance on external capital. That raises dilution and refinancing risks, limits strategic optionality, and makes the business more vulnerable to credit market conditions over the medium term.

Eroding equity and rising debt in 2025

Declining equity coupled with higher debt in 2025 signals mounting balance-sheet pressure. If losses persist, capital buffers may weaken further, increasing the cost of capital and potential for restrictive covenants that could constrain investment and operational flexibility.

Cacco, Inc. Business Overview & Revenue Model

Company Description

Cacco, Inc. (4166) is a technology-driven company specializing in software solutions for the healthcare sector. The company develops innovative applications aimed at improving patient care and operational efficiency within hospitals and clinics. Cacco, Inc. offers a range of products, including electronic health record (EHR) systems, telemedicine platforms, and healthcare analytics tools that empower healthcare providers to enhance service delivery and patient outcomes.

How the Company Makes Money

Cacco, Inc. generates revenue primarily through the sale of its software products and subscription-based services. The company charges healthcare providers a licensing fee for its EHR systems, which typically includes installation, maintenance, and support services. Additionally, Cacco, Inc. earns recurring revenue from subscription fees associated with its telemedicine platform, where healthcare facilities pay monthly or annual fees based on usage. Key revenue streams also include revenue from consulting services and customized solutions for larger healthcare organizations. Strategic partnerships with major healthcare systems and technology firms further bolster its earnings by expanding its customer base and enhancing its product offerings.

Cacco, Inc. Financial Statement Overview

Summary

Financials are pressured by three consecutive years of operating and net losses and negative operating/free cash flow (2023–2025). Balance-sheet leverage is relatively manageable, and 2025 shows improvement versus 2024 (narrower losses and smaller cash outflow), but profitability and cash generation remain meaningfully negative.

Income Statement

Revenue has been volatile: after declines in 2023–2024, 2025 returned to modest growth. Profitability is the core issue—after healthy profits in 2020–2022, the company swung to sizable operating losses and net losses in 2023–2025. A positive sign is margin recovery in 2025 versus 2024 (losses narrowed materially and gross margin improved), but results remain meaningfully negative overall.

Balance Sheet

Leverage looks manageable, with debt-to-equity staying low in most years and still moderate in 2025, which reduces balance-sheet risk. However, equity has declined from earlier periods, consistent with multiple years of losses, and total debt increased in 2025 versus 2023–2024. Overall, the balance sheet is not highly levered, but continued losses could further pressure equity over time.

Cash Flow

Cash generation has deteriorated: operating cash flow and free cash flow were strongly positive in 2021–2022, but turned negative in 2023–2025. The 2025 cash outflow is smaller than 2024 (an improvement), yet cash flow remains negative, which can increase funding needs if the trend persists.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	793.43M	819.44M	734.02M	952.00M	1.08B	951.14M
Gross Profit	514.85M	572.11M	445.02M	586.50M	729.95M	690.91M
EBITDA	-132.73M	-96.21M	-211.00M	-215.67M	244.87M	191.91M
Net Income	-170.32M	-137.69M	-255.03M	-320.00M	100.35M	120.31M
Balance Sheet
Total Assets	996.00M	1.00B	1.03B	1.29B	1.53B	1.42B
Cash, Cash Equivalents and Short-Term Investments	684.00M	762.44M	734.00M	941.00M	962.07M	800.65M
Total Debt	98.00M	186.65M	82.14M	96.00M	1.80M	6.08M
Total Liabilities	210.00M	299.83M	193.10M	214.00M	161.13M	143.98M
Stockholders Equity	786.00M	702.52M	832.17M	1.07B	1.37B	1.27B
Cash Flow
Free Cash Flow	0.00	-76.69M	-200.00M	-56.00M	212.50M	21.94M
Operating Cash Flow	0.00	-73.86M	-198.00M	-49.31M	250.38M	149.66M
Investing Cash Flow	0.00	-2.84M	-2.06M	-69.68M	-86.61M	-134.25M
Financing Cash Flow	0.00	104.51M	-5.68M	98.01M	-2.34M	-507.94M

Cacco, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 888.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4166, the sentiment is Negative. The current price of 888 is above the 20-day moving average (MA) of 744.65, above the 50-day MA of 800.88, and above the 200-day MA of 766.07, indicating a bearish trend. The MACD of -20.20 indicates Positive momentum. The RSI at 32.71 is Neutral, neither overbought nor oversold. The STOCH value of 3.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4166.

Cacco, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4397	68 Neutral	¥6.94B	17.21	―	―	11.32%	―
4168	67 Neutral	¥8.77B	10.03	―	0.70%	9.78%	-23.98%
5033	66 Neutral	¥4.80B	13.04	―	―	7.60%	19.13%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
4448	58 Neutral	¥11.71B	53.99	―	―	14.63%	-760.87%
4484	55 Neutral	¥5.07B	25.94	―	―	4.36%	-0.02%
4166	44 Neutral	¥1.92B	-13.96	―	―	12.27%	73.45%

Cacco, Inc. Corporate Events

Cacco Inc. Reports Q3 2025 Financial Results with Increased Sales Amid Losses

Cacco Inc. reported its financial results for the third quarter of fiscal year 2025, showing a notable increase in net sales by 14.9% compared to the previous year, despite continuing to operate at a loss. The company’s financial position remains stable with a high capital ratio, and no changes have been made to its dividend or financial forecasts, indicating a cautious approach towards future growth.

The most recent analyst rating on (JP:4166) stock is a Sell with a Yen637.00 price target. To see the full list of analyst forecasts on Cacco, Inc. stock, see the JP:4166 Stock Forecast page.